ALB and chronic myelogenous leukemia, BCR-ABL1 positive: In addition, a previous study showed that the NF-1G anti-CML antibody was specific to CML that had been produced from the nonenzymatic glycation between amino acid Lys in the presence of a reducing agent (NaCNBH3) or from bovine serum albumin-derived AGEs in the presence of the reducing agent [38].